Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001738995-18-000001
Filing Date
2018-04-30
Accepted
2018-04-27 17:36:16
Documents
1
Effectiveness Date
2018-04-30
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5566
  Complete submission text file 0001738995-18-000001.txt   6596
Mailing Address 13811 CICERONI LANE LOS ALTOS HILLS CA 94022
Business Address 13811 CICERONI LANE LOS ALTOS HILLS CA 94022 650-248-7914
Tulavi Therapeutics, Inc. (Filer) CIK: 0001738995 (see all company filings)

EIN.: 824929716 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-311235 | Film No.: 18785749